Restatement of Consolidated Financial Statements - Condensed Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended										6 Months Ended			9 Months Ended			12 Months Ended
	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Jun. 30, 2012	Mar. 31, 2012	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Operating activities:
Net (loss) income	$ (95,202)	$ 1,593	$ 4,589	$ 16,934	$ (28,180)	$ (7,048)	$ 29,245	$ 26,993	$ 26,758	$ 36,264	$ 21,523	$ 56,238	$ 75,616	$ 23,116	$ 49,190	$ 102,374	$ (72,086)	$ 21,010	$ 141,111
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization				9,363				7,652			18,886	16,415	12,514	28,083	25,732	19,891	38,627	34,918	25,268
Amortization (accretion) of debt discount (premium) and consumer loan premium (discount), net				(432)				(8,627)			(170)	(9,297)	(1,612)	(68)	(9,978)	(3,324)	2,611	(248)	(15,091)
Consumer loan loss provision				11,231				8,120			18,562	14,720	8,028	28,901	22,191	14,042	45,014	34,146	20,240
Deferred income taxes				694				2,213			(1,624)	1,399	465	(1,280)	244	(644)	(6,175)	(14,883)	1,290
Impairment of goodwill																	84,158	0	0
Reversal of contingent consideration																	(4,792)	0	0
Impairment of intangibles																	10,308	1,600	0
Restructuring																	6,121	0	0
Amortization of deferred financing costs				890				764			2,550	1,524		4,166	2,344		5,137	3,208	2,478
Amortization of prepaid commissions				2,226				649			5,144	1,464	1,399	10,039	2,902	2,886	14,525	4,573	467
Other adjustments				(206)				8,087			(789)	7,992	1,612	(753)	7,545	3,324	(2,251)	4,862	0
(Gain) loss on sale or disposal of assets				(6,422)				29			(6,081)	42	(174)	(6,137)	6,060	138	(5,371)	7,043	(1)
Gain on sale of loan portfolio				0							0			0			0
Stock compensation				1,207				799			8,189	2,915	3,238	9,487	5,046	5,191	6,845	7,128	6,660
Income from investments in unconsolidated affiliates		(2,117)	(492)	(1,271)		(4,328)	(4,125)	(5,038)	(4,197)	(4,577)	(1,763)	(9,163)	(8,738)	(3,880)	(13,491)	(12,935)	(5,948)	(13,240)	(16,038)
Impairment of investments			7,940		43,200						7,940			7,940			7,940	43,198	0
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable, net				3,179				2,236			9,501	9,706	8,037	1,577	2,304	(668)	(2,212)	3,412	1,330
Inventory, net				168				(11,908)			2,696	(3,034)	1,446	2,243	(51)	(874)	346	(9,722)	(4,017)
Prepaid expenses, other current assets and other assets, net				(17,870)				(18,343)			(20,990)	(8,435)	1,278	(35,349)	(19,776)	(7,683)	(28,807)	(17,671)	(15,196)
Accounts payable and other accrued expenses				(8,655)				11,214			(10,662)	(207)	(18,718)	(9,134)	14,105	(12,100)	9,136	21,283	1,596
Customer layaway deposits				(2,853)				(1,077)			353	812	206	(433)	588	(182)	(499)	1,416	218
Deferred gains and other long-term liabilities				167				573			(855)	557	10,856	(342)	330	722	(184)	(10,250)	(5,243)
Tax provision/benefit from stock compensation				0				(346)			0	(342)	(1,521)	0	(321)	(1,582)	609	(293)	(1,602)
Prepaid income taxes				2,544				8,614			(11,410)	3,362	(4,098)	(20,048)	(11,444)	(9,559)	(33,480)	(11,655)	(9,915)
Dividends from unconsolidated affiliates				2,597				1,595			2,597	4,828	4,788	5,129	8,418	5,560	5,129	10,632	5,560
Net cash provided by operating activities				13,491				34,199			43,597	91,496	94,622	43,257	91,938	104,577	74,701	120,467	139,115
Investing activities:
Loans made				(232,294)				(231,067)			(448,159)	(440,917)	(360,354)	(705,181)	(682,184)	(571,683)	(959,540)	(923,103)	(802,896)
Loans repaid				154,576				140,141			336,970	311,571	260,745	498,222	458,069	387,780	658,986	602,712	522,195
Recovery of pawn loan principal through sale of forfeited collateral				64,776				73,264			130,359	129,965	129,518	182,004	181,461	179,681	246,053	237,717	240,381
Additions to property and equipment				(5,615)				(8,906)			(10,643)	(23,506)	(20,842)	(15,930)	(33,351)	(33,193)	(22,964)	(46,698)	(45,796)
Acquisitions, net of cash acquired				(10,395)				(12,278)			(10,282)	(12,279)	(83,057)	(12,990)	(14,940)	(125,249)	(13,226)	(14,810)	(128,647)
Proceeds from sale of assets				9,882							10,631			10,631			10,631	0	0
Other investing activities											94			143
Investments in unconsolidated affiliates								(11,018)				(11,018)			(11,018)		0	(11,018)	0
Net cash used in investing activities				(19,070)				(49,864)			8,970	(46,184)	(73,990)	(43,101)	(101,963)	(162,664)	(80,060)	(155,200)	(214,763)
Financing activities:
Proceeds from exercise of stock options												6	634		45	647	0	45	649
Tax benefit from stock compensation				0				346			0	342	1,521	0	321	1,582	(609)	293	1,602
Taxes paid related to net share settlement of equity awards								(3,431)			(629)	(3,596)	(1,071)	(1,990)	(3,596)	(1,153)	(1,982)	(3,640)	(1,184)
Debt issuance costs				(3,080)							(5,176)	(259)		(12,686)			(14,017)	(1,283)	(3,225)
Payout of deferred and contingent consideration				(11,500)							(23,000)			(23,000)			(23,000)	(13,277)	0
Proceeds from issuance of convertible notes														(200,000)			(230,000)	0	0
Purchase of convertible notes hedges														(40,395)			(46,454)	0	0
Proceeds from issuance of warrants														(21,824)			(25,106)	0	0
Purchase of subsidiary shares from noncontrolling interest											(1,082)			(21,139)			(29,775)	(627)	0
Contributions from noncontrolling interest																	0	(5,839)	0
Change in restricted cash				154				5,754			(17,756)	5,728	(11,941)	(40,761)	(9,695)	(10,678)	(57,891)	1,326	(14,135)
Proceeds from revolving line of credit				80,887				80,125			217,493	148,265	321,617	389,900	403,131	594,809	359,900	510,680	792,927
Payments on revolving line of credit				(74,908)				(61,852)			(273,070)	(194,805)	(318,227)	(530,800)	(385,964)	(502,575)	(500,800)	(470,000)	(679,986)
Proceeds from bank borrowings				35,838				1,159			105,769	1,172		154,406	21,637	343	176,013	(15,432)	2,461
Payments on bank borrowings and capital lease obligations				(18,289)				(3,023)			(51,819)	(5,170)	(1,056)	(63,162)	(28,001)	(8,164)	(72,073)	9,725	(8,496)
Repurchase of common stock														(11,901)			(11,903)	0	0
Net cash provided by (used in) financing activities				9,102				19,078			(49,270)	(48,317)	(8,523)	20,296	(2,122)	74,811	32,515	23,649	90,613
Effect of exchange rate changes on cash and cash equivalents				66				(24)			(69)	(604)	(410)	(118)	(166)	488	(931)	360	890
Net increase (decrease) in cash and cash equivalents				3,589				3,389			3,228	(3,609)	11,699	20,334	(12,313)	17,212	26,225	(10,724)	15,855
Cash and cash equivalents at beginning of period	49,434	32,328	32,689	29,100	27,511	36,215	43,213	39,824	35,668		29,100	39,824	23,969	29,100	39,824	23,969	29,100	39,824	23,969
Cash and cash equivalents at end of period	55,325	49,434	32,328	32,689	29,100	27,511	36,215	43,213	41,181	35,668	32,328	36,215	35,668	49,434	27,511	41,181	55,325	29,100	39,824
Cash paid during the period for:
Interest																	16,361	12,553	2,480
Income taxes																	30,194	47,108	83,010
Non-cash investing and financing activities:
Pawn loans forfeited and transferred to inventory				63,256				69,370			118,050	130,675	123,587	171,288	192,150	177,490	241,696	261,837	248,090
Issuance of common stock due to acquisitions								38,647				38,705	11,615		38,705	17,984	0	38,705	17,984
Deferred consideration				5,350				24,000			5,331	24,000	5,785	2,692	25,872	916	2,674	25,872	938
Contingent consideration				4,792				4,792				4,792	23,000		7,148	23,000	0	248	23,432
Change in accrued additions to property and equipment				122				2,100			122		1,404		107	177	(420)	492	0
Note receivable from sale of assets											15,903
Issuance of common stock due to purchase of subsidiary shares from noncontrolling interest								10,404			(634)	10,404		(13,274)	10,404		0	10,404	0
Purchase of shares from noncontrolling interest											(619)						0	(788)	0
Issuance of common stock to 401(k) plan														557			557	556	459
Equity adjustment due to noncontrolling interest purchase														6,588			6,609	0	0
Receivable from sale of portfolio				1,000										0			0
Receivable from issuance of convertible notes														30,000
Payable to purchase convertible note hedge														6,059
Warrants receivable related to issuance of convertible notes														3,282
Deferred finance cost payable related to convertible notes														2,400			1,092	0	0
Payable to purchase additional shares of noncontrolling interest														8,636
As Previously Reported [Member]
Operating activities:
Net (loss) income		12,343	9,067	24,395		(4,840)	34,880	32,155	29,711	37,373	33,462	67,035	76,725	45,805	62,195	106,436	(41,532)	38,425	150,577
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization				9,363				7,652			18,886	16,415	12,514	28,083	25,732	19,891	38,627	34,918	25,268
Amortization (accretion) of debt discount (premium) and consumer loan premium (discount), net				(432)				0			0	0	0	0	0	0	2,611	(248)	(15,091)
Consumer loan loss provision				11,350				7,990			17,365	12,900	6,761	26,335	19,982	12,136	42,501	30,740	17,833
Deferred income taxes				693				2,214			(1,624)	1,400	465	(1,280)	245	(644)	(11,973)	(14,854)	2,761
Impairment of goodwill																	84,158
Reversal of contingent consideration																	(4,792)
Impairment of intangibles																	11,908	0
Restructuring																	6,121
Amortization of deferred financing costs				890				0			0	0		0	0		5,137	3,208	2,478
Amortization of prepaid commissions				1,937				0			0	0	0	0	0	0	16,893	4,182	396
Other adjustments				(114)				0			2,551	0	0	4,252	73	0	(2,453)	3,713
(Gain) loss on sale or disposal of assets				(6,422)				29			(6,081)	42	(174)	(6,137)	6,060	138	(5,371)	7,043	(1)
Gain on sale of loan portfolio				(4,543)							(5,784)			(14,312)			(33,000)
Stock compensation				1,236				925			8,268	3,054	3,238	9,929	5,202	5,191	7,341	7,314	6,714
Income from investments in unconsolidated affiliates		(2,117)	(492)	(1,271)		(4,328)	(4,125)	(5,038)	(4,197)	(4,577)	(1,763)	(9,163)	(8,738)	(3,880)	(13,491)	(12,935)	(5,948)	(11,878)	(17,400)
Impairment of investments			7,940								7,940			7,940			7,940	44,598
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable, net				(2,292)				(5,192)			2,625	2,366	6,551	(4,407)	(4,203)	1,150	(2,967)	(7,143)	(5,359)
Inventory, net				(385)				(11,908)			1,777	(3,034)	1,446	1,061	(51)	(874)	(898)	(9,722)	(4,017)
Prepaid expenses, other current assets and other assets, net				(17,870)				(17,727)			(15,778)	(7,072)	2,644	(25,402)	(13,119)	(4,845)	(29,294)	(17,671)	(15,196)
Accounts payable and other accrued expenses				(8,022)				9,323			(11,155)	(2,743)	(18,718)	(7,221)	7,330	(12,100)	12,109	16,766	4,347
Customer layaway deposits				(2,853)				(1,077)			353	812	206	(433)	588	(182)	(499)	1,416	218
Deferred gains and other long-term liabilities				335				83			1,554	350	10,856	943	439	722	11	(8,898)	(8,782)
Tax provision/benefit from stock compensation				390				(346)			411	(342)	(1,521)	570	(321)	(1,582)	609	(293)	(1,602)
Prepaid income taxes				8,472				9,830			(1,987)	7,320	(1,949)	(6,196)	(5,664)	(8,370)	(13,124)	(5,775)	(7,787)
Dividends from unconsolidated affiliates				2,597				1,595			2,597	4,828	4,788	5,129	8,418	5,560	5,129	10,632	5,560
Net cash provided by operating activities				17,454				30,508			53,617	94,168	95,094	60,779	99,415	109,692	89,244	126,473	140,917
Investing activities:
Loans made				(232,294)				(231,067)			(448,159)	(440,917)	(360,354)	(705,181)	(682,184)	(571,683)	(959,540)	(923,103)	(802,896)
Loans repaid				150,206				142,250			325,171	307,930	260,289	476,196	451,182	382,854	628,710	597,528	520,193
Recovery of pawn loan principal through sale of forfeited collateral				64,776				73,264			130,359	129,965	129,518	182,004	181,461	179,681	246,053	237,717	240,381
Additions to property and equipment				(5,615)				(8,906)			(10,643)	(23,506)	(20,842)	(15,930)	(33,351)	(33,193)	(22,964)	(46,698)	(45,796)
Acquisitions, net of cash acquired				(10,395)				(12,278)			(10,282)	(12,279)	(83,057)	(12,990)	(14,940)	(125,249)	(13,226)	(14,810)	(128,647)
Proceeds from sale of assets				28,980							29,546			44,568			86,129
Other investing activities											94			143
Investments in unconsolidated affiliates								(11,018)				(11,018)			(11,018)			(11,018)
Net cash used in investing activities				(4,342)				(47,755)			16,086	(49,825)	(74,446)	(31,190)	(108,850)	(167,590)	(34,838)	(160,384)	(216,765)
Financing activities:
Proceeds from exercise of stock options												6	634		45	647		45	649
Tax benefit from stock compensation				(389)				346			(411)	342	1,521	(569)	321	1,582	(609)	293	1,602
Taxes paid related to net share settlement of equity awards								(3,431)			(629)	(3,596)	(1,071)	(1,990)	(3,596)	(1,153)	(1,982)	(3,640)	(1,184)
Debt issuance costs				(3,080)							(5,176)	(259)		(12,686)			(14,017)	(1,283)	(3,225)
Payout of deferred and contingent consideration				(11,500)							(23,000)			(23,000)			(23,000)	(13,277)
Proceeds from issuance of convertible notes														(200,000)			(230,000)
Purchase of convertible notes hedges														(40,395)			(46,454)
Proceeds from issuance of warrants														(21,824)			(25,106)
Purchase of subsidiary shares from noncontrolling interest											(1,082)			(21,139)			(29,775)	(627)
Contributions from noncontrolling interest																		(5,839)
Change in restricted cash				(1,263)				2,298			(25,099)	2,303	(935)	(29,992)	96	(1,085)	(63,207)	(110)	(5,482)
Proceeds from revolving line of credit				80,887				80,125			217,493	148,265	321,617	389,900	403,131	594,809	359,900	510,680	792,927
Payments on revolving line of credit				(74,908)				(61,852)			(273,070)	(194,805)	(318,227)	(530,800)	(385,964)	(502,575)	(500,800)	(470,000)	(679,986)
Proceeds from bank borrowings				16,703				1,159			86,661	1,172		102,138	21,637	343	103,178	(15,432)	2,461
Payments on bank borrowings and capital lease obligations				(17,496)				(3,023)			(49,497)	(5,170)	(1,056)	(57,578)	(28,001)	(8,164)	(60,299)	9,725	(8,496)
Repurchase of common stock														(11,901)			(11,903)
Net cash provided by (used in) financing activities				(11,046)				15,622			(73,810)	(51,742)	2,483	(16,188)	7,669	84,404	(33,862)	22,213	99,266
Effect of exchange rate changes on cash and cash equivalents				103				(184)			(12)	365	(426)	281	(756)	299	(532)	(462)	1,090
Net increase (decrease) in cash and cash equivalents				2,169				(1,809)			(4,119)	(7,034)	22,705	13,682	(2,522)	26,805	20,012	(12,160)	24,508
Cash and cash equivalents at beginning of period	49,999	32,198	38,486	36,317	45,955	41,443	46,668	48,477	46,674		36,317	48,477	23,969	36,317	48,477	23,969	36,317	48,477	23,969
Cash and cash equivalents at end of period	56,329	49,999	32,198	38,486	36,317	45,955	41,443	46,668	50,774	46,674	32,198	41,443	46,674	49,999	45,955	50,774	56,329	36,317	48,477
Cash paid during the period for:
Interest																	16,361	12,553	2,480
Income taxes																	30,194	47,108	83,010
Non-cash investing and financing activities:
Pawn loans forfeited and transferred to inventory				63,256				69,370			118,050	130,675	123,587	171,288	192,150	177,490	241,696	261,837	248,090
Issuance of common stock due to acquisitions								38,647				38,705	11,615		38,705	17,984		38,705	17,984
Deferred consideration				5,350				24,000			5,331	24,000	5,785	2,692	25,872	916	2,674	25,872	938
Contingent consideration				4,792				4,792				4,792	23,000		7,148	23,000		248	23,432
Change in accrued additions to property and equipment				122				2,100			122		1,404		107	177	(420)	492
Note receivable from sale of assets											15,903
Issuance of common stock due to purchase of subsidiary shares from noncontrolling interest								10,404			(634)	10,404		(6,609)	10,404			10,404
Purchase of shares from noncontrolling interest											(619)							(788)
Issuance of common stock to 401(k) plan														557			557	556	459
Equity adjustment due to noncontrolling interest purchase														6,588			6,609
Receivable from sale of portfolio				1,000										38,269			43,780
Receivable from issuance of convertible notes														30,000
Payable to purchase convertible note hedge														6,059
Warrants receivable related to issuance of convertible notes														3,282
Deferred finance cost payable related to convertible notes														2,400			1,092
Payable to purchase additional shares of noncontrolling interest														8,636
Effect of Restatement [Member]
Operating activities:
Net (loss) income		(10,750)	(4,478)	(7,461)		(2,208)	(5,635)	(5,162)	(2,953)	(1,109)	(11,939)	(10,797)	(1,109)	(22,689)	(13,005)	(4,062)	(30,554)	(17,415)	(9,466)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization				0				0			0	0	0	0	0	0	0	0	0
Amortization (accretion) of debt discount (premium) and consumer loan premium (discount), net				0				(8,627)			(170)	(9,297)	(1,612)	(68)	(9,978)	(3,324)	0	0	0
Consumer loan loss provision				(119)				130			1,197	1,820	1,267	2,566	2,209	1,906	2,513	3,406	2,407
Deferred income taxes				1				(1)			0	(1)	0	0	(1)	0	5,798	(29)	(1,471)
Impairment of goodwill																	0
Reversal of contingent consideration																	0
Impairment of intangibles																	(1,600)	1,600
Restructuring																	0
Amortization of deferred financing costs				0				764			2,550	1,524		4,166	2,344		0	0	0
Amortization of prepaid commissions				289				649			5,144	1,464	1,399	10,039	2,902	2,886	(2,368)	391	71
Other adjustments				(92)				8,087			(3,340)	7,992	1,612	(5,005)	7,472	3,324	202	1,149
(Gain) loss on sale or disposal of assets				0				0			0	0	0	0	0	0	0	0	0
Gain on sale of loan portfolio				4,543							5,784			14,312			33,000
Stock compensation				(29)				(126)			(79)	(139)	0	(442)	(156)	0	(496)	(186)	(54)
Income from investments in unconsolidated affiliates		0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	(1,362)	1,362
Impairment of investments			0								0			0			0	(1,400)
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable, net				5,471				7,428			6,876	7,340	1,486	5,984	6,507	(1,818)	755	10,555	6,689
Inventory, net				553				0			919	0	0	1,182	0	0	1,244	0	0
Prepaid expenses, other current assets and other assets, net				0				(616)			(5,212)	(1,363)	(1,366)	(9,947)	(6,657)	(2,838)	487	0	0
Accounts payable and other accrued expenses				(633)				1,891			493	2,536	0	(1,913)	6,775	0	(2,973)	4,517	(2,751)
Customer layaway deposits				0				0			0	0	0	0	0	0	0	0	0
Deferred gains and other long-term liabilities				(168)				490			(2,409)	207	0	(1,285)	(109)	0	(195)	(1,352)	3,539
Tax provision/benefit from stock compensation				(390)				0			(411)	0	0	(570)	0	0	0	0	0
Prepaid income taxes				(5,928)				(1,216)			(9,423)	(3,958)	(2,149)	(13,852)	(5,780)	(1,189)	(20,356)	(5,880)	(2,128)
Dividends from unconsolidated affiliates				0				0			0	0	0	0	0	0	0	0	0
Net cash provided by operating activities				(3,963)				3,691			(10,020)	(2,672)	(472)	(17,522)	(7,477)	(5,115)	(14,543)	(6,006)	(1,802)
Investing activities:
Loans made				0				0			0	0	0	0	0	0	0	0	0
Loans repaid				4,370				(2,109)			11,799	3,641	456	22,026	6,887	4,926	30,276	5,184	2,002
Recovery of pawn loan principal through sale of forfeited collateral				0				0			0	0	0	0	0	0	0	0	0
Additions to property and equipment				0				0			0	0	0	0	0	0	0	0	0
Acquisitions, net of cash acquired				0				0			0	0	0	0	0	0	0	0	0
Proceeds from sale of assets				(19,098)							(18,915)			(33,937)			(75,498)
Other investing activities											0			0
Investments in unconsolidated affiliates								0				0			0			0
Net cash used in investing activities				(14,728)				(2,109)			(7,116)	3,641	456	(11,911)	6,887	4,926	(45,222)	5,184	2,002
Financing activities:
Proceeds from exercise of stock options												0	0		0	0		0	0
Tax benefit from stock compensation				389				0			411	0	0	569	0	0	0	0	0
Taxes paid related to net share settlement of equity awards								0			0	0	0	0	0	0	0	0	0
Debt issuance costs				0							0	0		0			0	0	0
Payout of deferred and contingent consideration				0							0			0			0	0
Proceeds from issuance of convertible notes														0			0
Purchase of convertible notes hedges														0			0
Proceeds from issuance of warrants														0			0
Purchase of subsidiary shares from noncontrolling interest											0			0			0	0
Contributions from noncontrolling interest																		0
Change in restricted cash				1,417				3,456			7,343	3,425	(11,006)	(10,769)	(9,791)	(9,593)	5,316	1,436	(8,653)
Proceeds from revolving line of credit				0				0			0	0	0	0	0	0	0	0	0
Payments on revolving line of credit				0				0			0	0	0	0	0	0	0	0	0
Proceeds from bank borrowings				19,135				0			19,108	0		52,268	0	0	72,835	0	0
Payments on bank borrowings and capital lease obligations				(793)				0			(2,322)	0	0	(5,584)	0	0	(11,774)	0	0
Repurchase of common stock														0			0
Net cash provided by (used in) financing activities				20,148				3,456			24,540	3,425	(11,006)	36,484	(9,791)	(9,593)	66,377	1,436	(8,653)
Effect of exchange rate changes on cash and cash equivalents				(37)				160			(57)	(969)	16	(399)	590	189	(399)	822	(200)
Net increase (decrease) in cash and cash equivalents				1,420				5,198			7,347	3,425	(11,006)	6,652	(9,791)	(9,593)	6,213	1,436	(8,653)
Cash and cash equivalents at beginning of period	(565)	130	(5,797)	(7,217)	(18,444)	(5,228)	(3,455)	(8,653)	(11,006)		(7,217)	(8,653)	0	(7,217)	(8,653)	0	(7,217)	(8,653)	0
Cash and cash equivalents at end of period	$ (1,004)	$ (565)	$ 130	(5,797)	$ (7,217)	$ (18,444)	$ (5,228)	(3,455)	$ (9,593)	$ (11,006)	130	(5,228)	(11,006)	(565)	(18,444)	(9,593)	(1,004)	(7,217)	(8,653)
Cash paid during the period for:
Interest																	0	0	0
Income taxes																	0	0	0
Non-cash investing and financing activities:
Pawn loans forfeited and transferred to inventory				0				0			0	0	0	0	0	0	0	0	0
Issuance of common stock due to acquisitions								0				0	0		0	0		0	0
Deferred consideration				0				0			0	0	0	0	0	0	0	0	0
Contingent consideration				0				0				$ 0	0		0	0		0	0
Change in accrued additions to property and equipment				0				$ 0			0		$ 0		$ 0	$ 0	0	0
Note receivable from sale of assets											0
Issuance of common stock due to purchase of subsidiary shares from noncontrolling interest														(6,665)				0
Purchase of shares from noncontrolling interest											$ 0							0
Issuance of common stock to 401(k) plan														0			0	$ 0	$ 0
Equity adjustment due to noncontrolling interest purchase														0			0
Receivable from sale of portfolio				$ 0										(38,269)			(43,780)
Receivable from issuance of convertible notes														0
Payable to purchase convertible note hedge														0
Warrants receivable related to issuance of convertible notes														0
Deferred finance cost payable related to convertible notes														0			$ 0
Payable to purchase additional shares of noncontrolling interest														$ 0